Karolinska Development AB (publ)
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KDEVF research report →
About the company
Karolinska Development AB (publ) operates as a venture capital firm, primarily focused on providing funding to nascent companies across seed, early, and growth stages. Its investment strategy targets a wide array of life science domains, including pharmaceutical and genetic research and development, medical advancements, healthcare technology, innovative drug delivery systems, biotechnology, and specialized tools and service providers for the life science industry. The company strategically prioritizes investment opportunities within the Nordic region, specifically highlighting Sweden, Iceland, Norway, Finland, and Denmark.
- CEO
- Viktor Drvota
- IPO
- 2019
- Employees
- 8
- HQ
- Solna, SE
Price Chart
- Market Cap
- $68.85M
- P/E
- -0.36
- P/S
- 25.45
- P/B
- 0.12
- EV/EBITDA
- 0.43
- Div Yield
- 0.00%
- Gross Margin
- 81.84%
- Op Margin
- -7806.67%
- Net Margin
- -7797.16%
- ROE
- -19.50%
- ROIC
- -19.26%
- Revenue
- $10.77M · 0.00%
- Net Income
- $-193,368,709 · 0.00%
- EPS
- $-0.58 · 0.00%
- Op Income
- $-193,637,027
- FCF YoY
- 0.00%
- 52W High
- $0.61
- 52W Low
- $0.26
- 50D MA
- $0.26
- 200D MA
- $0.26
- Beta
- 0.24
- Avg Volume
- 0
Get TickerSpark's AI analysis on KDEVF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our KDEVF coverage
Recent articles, reports, and earnings notes.
No research on KDEVF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate KDEVF report →Similar companies
Peers in the same neighborhood.